Previous Article | Next Article 
Journal of Bacteriology, September 2001, p. 5371-5375, Vol. 183, No. 18
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.18.5371-5375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Hop Resistance in the Beer Spoilage Bacterium Lactobacillus
brevis Is Mediated by the ATP-Binding Cassette Multidrug
Transporter HorA
Kanta
Sakamoto,1
Abelardo
Margolles,2,
Hendrik W.
van Veen,2,
and
Wil N.
Konings2,*
Brewing Research & Development Laboratory,
Asahi Breweries, Ltd., Moriya-machi, Kitasoma-gun, Ibaraki 302-0106, Japan,1 and Department of Microbiology,
Groningen Biomolecular Sciences and Biotechnology Institute,
University of Groningen, The Netherlands2
Received 21 November 2000/Accepted 12 June 2001
 |
ABSTRACT |
Lactobacillus brevis is a major contaminant of spoiled
beer. The organism can grow in beer in spite of the presence of
antibacterial hop compounds that give the beer a bitter taste. The hop
resistance in L. brevis is, at least in part, dependent on
the expression of the horA gene. The deduced amino acid
sequence of HorA is 53% identical to that of LmrA, an ATP-binding
cassette multidrug transporter in Lactococcus lactis. To
study the role of HorA in hop resistance, HorA was functionally
expressed in L. lactis as a hexa-histidine-tagged protein
using the nisin-controlled gene expression system. HorA expression
increased the resistance of L. lactis to hop compounds and
cytotoxic drugs. Drug transport studies with L. lactis
cells and membrane vesicles and with proteoliposomes containing
purified HorA protein identified HorA as a new member of the ABC family of multidrug transporters.
 |
INTRODUCTION |
Bacterial spoilage of beer products
causes a serious problem in the brewing industry. The iso-
-acids,
derived from the flowers of the hop plant (Humulus lupulus
L.), give beer a bitter taste and exert bacteriostatic effects on most
gram-positive bacteria due to their ability to dissipate the proton
motive force (13, 16, 17). A few lactic acid bacteria,
such as Lactobacillus spp., are tolerant towards
iso-
-acids and are able to grow in hopped beer (14,
15). At present, the molecular mechanisms that underlie the hop
resistance in lactic acid bacteria are not well understood.
Previously, Sami and colleagues have isolated a hop-tolerant
Lactobacillus brevis strain, ABBC45, in which the plasmid
pRH45 confers hop resistance on the cells (10). pRH45
harbors the horA gene, whose corresponding deduced
amino acid sequence is 53% identical to that of the multidrug
transporter LmrA in Lactococcus lactis (11,
18). LmrA is a multidrug transporter able to transport a wide
variety of amphiphilic compounds, including antibiotics and anticancer
drugs, from the inner leaflet of the cytoplasmic membrane (1, 9,
12). Unlike other known bacterial multidrug resistance proteins,
LmrA is an ATP-binding cassette (ABC) transporter (4, 21).
The protein contains an N-terminal membrane domain with six
transmembrane segments followed by the ABC domain. Surprisingly, LmrA
is a structural and functional homologue of the human multidrug resistance P-glycoprotein, overexpression of which is one of the principal causes of resistance of human cancer cells to chemotherapy, and can even complement P-glycoprotein in human lung fibroblast cells
(19).
In this work, HorA was functionally overexpressed in L. lactis as a hexa-histidine-tagged protein. The hop resistance of
L. lactis cells was increased significantly as a result of
HorA expression. The protein was purified by
Ni2+-nitrilotriacetic acid (NTA) affinity chromatography
and functionally reconstituted into proteoliposomes prepared from
L. lactis lipids. Transport studies with cells, membrane
vesicles, and proteoliposomes identified HorA as a multidrug
transporter which mediates the extrusion of structurally unrelated
compounds, including iso-
-acids.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
Lactobacillus
brevis ABBC45 (10) was grown aerobically at 30°C in
MRS broth (Merck). Lactococcus lactis subsp.
lactis NZ9000 was used as a host for the nisin-controlled
gene expression (NICE) vector pNZ8048 (3) and its
horA-containing derivatives. L. lactis was grown
at 30°C in M17 broth (Difco) supplemented with 5 µg of
chloramphenicol/ml and with 0.5% glucose (wt/vol) when appropriate.
Genetic manipulations.
The horA gene was
amplified from pRH45 by PCR using the oligonucleotide 5'-GGG ATA
CTG CAG CCA TGG GGC ATC ACC ATC ACC ATC ACG ATG ACG ATG ACA AAG CCC AAG
CTC AGT CCA AGA ACA ATA CCA AG-3' to introduce a PstI
site, NcoI site, and hexa-histidine tag at the 5' end of
horA and the oligonucleotide 5'-GTA CCC TTA TCT AGA TTA
TCA CCC GTT GCT C-3' to introduce an XbaI site at the 3' end of horA. The PCR product was cloned as a
PstI-XbaI fragment into pAlter-1 (Promega) using
Escherichia coli JM109 as a host. After the internal
NcoI site in horA was removed silently by
site-directed mutagenesis using the Altered Sites II in vitro
Mutagenesis System (Promega) and the mutagenic oligonucleotide
5'-CCA GGA CCA TCG CCA TCA TGA CC-3', the horA
gene was cloned as an NcoI-XbaI fragment into
pNZ8048, giving pNZHHorA. Finally, horA was sequenced to ensure that only the intended changes had been introduced.
Hop resistance.
To test the hop resistance of L. lactis NZ9000 harboring pNZ8048 or pNZHHorA, overnight cultures
were diluted into fresh medium and grown to mid-exponential growth
phase. Subsequently the cells were diluted to an optical density at 690 nm (OD690) of 0.1 in M17 medium containing 5 µg of
chloramphenicol/ml, about 63 pg of nisin A/ml (through a 1-in-160,000
dilution of the supernatant of the nisin A-producing L. lactis strain NZ9700 [3]), and hop compounds
(11) at various final concentrations (see Fig. 2).
Aliquots of 200 µl of the cell suspensions were dispensed into a
sterile low-protein-binding microplate (Greiner). Sterile silicon oil
(50 µl) was pipetted on top of the sample to prevent evaporation.
Growth was monitored at 15°C by measuring the OD690 every
40 min with a multiscan photometer (Titertek multiskan MCC/340 MKII;
Flow Laboratories).
Solubilization, purification, and reconstitution of
histidine-tagged HorA.
L. lactis NZ9000 cells harboring
pNZ8048 or pNZHhorA were grown at 30°C to an OD690 of
about 0.5. Subsequently, about 10 ng of nisin A/ml was added to the
culture through a 1-in-1,000 dilution of the supernatant of the nisin
A-producing L. lactis strain NZ9700 (3). The
cell suspensions were further incubated at 30°C for 2 h, after
which the cells were collected by centrifugation. The inside-out
membrane vesicles of HorA-expressing L. lactis cells were
prepared using a French pressure cell, as described (5, 8,
20), and stored in liquid nitrogen. His-tagged HorA was solubilized with 1% n-dodecyl-
-maltoside as described
previously (5). Insoluble components were removed by
ultracentrifugation at 280,000 × g for 15 min at
4°C. The soluble fraction was mixed with Ni-NTA-agarose (Qiagen Inc.)
(20 µl of resin/mg of protein) which was equilibrated with buffer A
(50 mM KPi [pH 8.0] supplemented with 100 mM NaCl, 10% [vol/vol]
glycerol and 0.05% n-dodecyl-
-maltoside). The
agarose suspension was shaken gently at 4°C for 1 h. The resin was transferred to a Bio-spin column (Bio-Rad) and washed with 20 column volumes of buffer A containing 20 mM imidazole and subsequently with 10 column volumes of buffer A containing 40 mM imidazole. The
protein was eluted with buffer A, adjusted to pH 7.0, and supplemented
with 250 mM imidazole. For reconstitition of purified HorA in
proteoliposomes of L. lactis lipids, total lipids of
L. lactis were extracted and purified as described
previously (5). Unilamellar liposomes with a relatively
homogeneous size were prepared by freezing in liquid nitrogen, slow
thawing at room temperature, and extrusion of the liposomes 11 times
through a 400-nm-pore-size polycarbonate filter. The liposomes were
diluted to 1 mg of phospholipid/ml, and dodecyl maltoside was added to a final concentration of 4 µmol/ml to destabilize the liposomes. The
purified HorA was mixed with dodecyl maltoside-destabilized liposomes
at a protein/lipid ratio of 1:100 (wt/wt), after which the suspension
was incubated for 30 min at room temperature under gentle agitation.
The detergent was removed by absorption to polystyrene beads (Bio-Beads
SM-2; Bio-Rad) as described previously (5). Finally, the
proteoliposomes were collected by ultracentrifugation at
280,000 × g for 15 min at 10°C, resuspended in 50 mM
KPi (pH 7.0), and stored in liquid nitrogen.
Transport assays. (i) Ethidium transport.
L.
lactis NZ9000 cells harboring pNZ8048 or pNZHhorA were grown at
30°C to an OD690 of about 0.5. Subsequently, about 10 ng of nisin A/ml was added to the culture through a 1-in-1,000 dilution of
the supernatant of the nisin A-producing L. lactis strain
NZ9700 (3). The cell suspensions were further incubated at
30°C for 2 h, after which the cells were collected by
centrifugation at 4°C at 8,000 × g for 10 min. The
cells were washed with 50 mM KPi (pH 7.0) containing 5 mM
MgSO4. The washed cell suspensions (OD690 of
0.5) were incubated for 10 min at 30°C in the presence of 10 µM
ethidium bromide to allow the diffusion of ethidium bromide into the
cells. The ethidium bromide efflux was initiated by the addition of 25 mM glucose. The fluorescence of ethidium bromide was monitored at
20°C with a Perkin-Elmer LS 50B fluorimeter using excitation and
emission wavelengths of 500 and 580 nm, respectively, and slit widths
of 5 and 15 nm, respectively (18). To study the effect of
ortho-vanadate on the accumulation of ethidium in HorA-expressing and nonexpressing L. lactis cells, cells
were grown in medium supplemented with 30 mM arginine rather than
glucose (6). After the induction of HorA expression as
described above, cells were washed with 50 mM (K)HEPES (pH 7.4)
supplemented with 2 mM MgSO4. Washed cells
(OD690 of 0.5) were de-energized by incubation for 40 min
at 30°C. Subsequently, cells were reenergized for 7.5 min by the
addition of 30 mM arginine, in the presence or absence of 0.5 mM
ortho-vanadate. Finally, 10 µM ethidium bromide was added
to the cell suspensions, and the fluorescence of ethidium bromide was
measured at 20°C as described above.
(ii) Hoechst 33342 transport.
For the transport of Hoechst
33342 in inside-out membrane vesicles, membrane vesicles were diluted
to a final concentration of 0.5 mg of membrane protein/ml in KPi (pH
7.5) containing 2 mM MgSO4, 5 mM phosphocreatine, and 0.1 mg of creatine kinase/ml. Valinomycin and nigericin were added to a
final concentration of 0.4 µM each, to dissipate the membrane
potential and transmembrane pH gradient, respectively. After an
incubation for 1 min at 20°C, 2.3 µM Hoechst 33342 was added. The
fluorescence of Hoechst 33342 was measured at 20°C using a
Perkin-Elmer LS 50B fluorimeter with excitation and emission
wavelengths of 355 and 457 nm, respectively, and slit widths of 3 nm
each. After the Hoechst 33342 fluorescence had reached a steady state,
Hoechst 33342 transport was initiated by the addition of 2 mM
Mg-ATP. In control experiments, Mg-ATP
S was used rather than
Mg-ATP. For the transport of Hoechst 33342, HorA-containing
proteoliposomes were thawed slowly and extruded 11 times through a
400-nm-pore-size polycarbonate filter. Subsequently proteoliposomes
were washed twice and resuspended in 50 mM KPi (pH 7.5) or (K)HEPES (pH
7.5). The Hoechst 33342 transport assay was performed as described
above in the absence of ionophores, using proteoliposomes at a final
concentration of 0.01 mg of protein/ml.
 |
RESULTS |
Overexpression of hexa-histidine-tagged HorA.
Using the
polymerase chain reaction, the horA gene on plasmid pRH45 of
L. brevis ABBC45 was cloned into the lactococcal NICE expression vector pNZ8048 under the control of the nisin-inducible nisA
promoter. A hexa-histidine tag was added to the amino terminus of HorA
to facilitate the purification of the protein by Ni2+-NTA
affinity chromatography. Induction of HorA expression in L. lactis NZ9000 by the addition of nisin A to exponentially growing cells resulted in the expression of a plasma membrane-associated 66-kDa
polypeptide, which could be detected on a Western blot by using an
anti-hexa-histidine-tag monoclonal antibody (Fig. 1). HorA expression in cells was maximal
after an induction time of 2 h. Quantitative immunoblotting and
densitometry analysis revealed a HorA expression level of about 30% of
the total membrane protein under these conditions (data not shown).
Densitometric analysis of Coomassie-stained sodium dodecyl
sulfate-polyacrylamide gels of the membrane fraction of HorA-expressing
cells and the purified HorA indicated a purity of HorA of more than
95% (data not shown).

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Expression, purification, and functional reconstitution
of hexa-histidine-tagged HorA. The HorA protein was overexpressed in
L. lactis as a hexa-histidine-tagged protein using the NICE
system. A silver-stained sodium dodecyl sulfate-polyacrylamide gel is
shown. Lane 1, total membrane protein (20 ug) of L. lactis
harboring pNZHHorA; lane 2, soluble fraction (20 µg of protein) of a
lysate of HorA-expressing cells; lane 3, Western blot of the membrane
fraction (20 µg of protein) of HorA-expressing cells, with
anti-hexa-histidine antibody; lane 4, flowthrough fraction of membrane
proteins (20 µl of the total fraction of 2 ml) eluted from the
Ni2+-NTA resin; lanes 5, 6, and 7, histidine-tagged HorA
eluted from the NTA resin (20 µl out of the total fraction of 2 ml)
in three consecutive steps with buffer supplemented with 250 mM
imidazole; lane 8, molecular mass markers; lane 9, HorA reconstituted
into proteoliposomes. Lanes 3 and 9 are Western blots; the other lanes
are silver-stained gels. The arrow indicates the position of
hexa-histidine-tagged HorA protein.
|
|
HorA overexpression confers hop resistance on L. lactis
cells.
The hop resistance of L. lactis NZ9000 cells
harboring pNZHHorA was compared with the hop resistance of cells
harboring the pNZ8048 control vector. In the absence of
iso-
-acids the HorA-expressing cells grew slightly more
slowly and reached a slightly lower cell density than control cells
(Fig. 2A). A similar effect on the growth
of L. lactis was observed for LmrA-expressing cells
(5). Figure 2B shows the inhibitory effects of various
concentrations of the iso-
-acid compounds on the growth of
HorA-expressing cells. The inhibition of growth by 100, 200, and 300 µM hop compounds is significantly higher for control cells than for
HorA-expressing cells, indicating that HorA expression in L. lactis results in an increased hop resistance of the organism.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Growth of control L. lactis harboring
pNZ8048 (triangles) and of HorA-expressing L. lactis
harboring pNZHHorA (squares) in the absence of iso- -acids. (B)
Inhibition of growth by iso- -acids of control L. lactis
(triangles) and of HorA-expressing L. lactis (squares).
Cells were grown at 15°C in the absence or presence of a 50, 100, 200, or 300 µM concentration of iso- -acids. The OD690
was measured every 10 min. The growth rates were determined at the
mid-exponential phase.
|
|
HorA is active as a multidrug transporter. (i) Ethidium transport
in cells.
HorA is a homologue of the ABC multidrug transporter
LmrA in L. lactis (11, 21). Fluorimetric
ethidium transport assays were performed to test if HorA can mediate
the transport of ethidium, a typical substrate for LmrA. Washed
cell suspensions of L. lactis NZ9000 containing
pNZHHorA or pNZ8048 were preequilibrated in the presence of
10 µM ethidium bromide. Subsequently the cells were energized through
the addition of 20 mM glucose. The energization of cells resulted in an
increased rate of ethidium extrusion for the HorA-expressing cells
compared to the rate observed for nonexpressing control cells,
suggesting that HorA is able to mediate the active extrusion of
ethidium bromide (Fig. 3A). HorA is a
member of the ABC superfamily and should display an ATP-dependent
extrusion activity. To analyze whether ethidium efflux was coupled to
ATP hydrolysis, the effect of the ABC transporter inhibitor
ortho-vanadate was examined. For this purpose, cells were
preenergized with 30 mM L-arginine and preincubated in the
presence of 0.5 mM ortho-vanadate. In this way, cells could
generate metabolic energy by metabolizing arginine via the
arginine-deiminase pathway (6). In contrast to glycolysis,
which is inhibited by ortho-vanadate, the arginine-deiminase pathway is not affected by this inhibitor. Ortho-vanadate
increased the level of ethidium uptake in HorA-expressing cells, while
no increase was observed in control cells. These observations
indicate inhibition by ortho-vanadate of HorA-mediated
efflux of ethidium (Fig. 3B and C).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Ethidium transport in HorA-expressing cells and
nonexpressing cells of L. lactis. Panel (A) De-energized
HorA-expressing and control cells (0.2 mg of protein/ml;
OD690, 0.5) were preequilibrated with 10 µM ethidium
bromide at 30°C. The development of fluorescence of the DNA-ethidium
complex in the cell suspension was monitored at 20°C over time. At
the arrow, 25 mM glucose was added. (B) Effect of
ortho-vanadate on the accumulation of ethidium bromide in
control cells. Cells were energized with arginine and incubated for 7.5 min in the presence or absence of 0.5 mM ortho-vanadate
prior to the addition of 10 µM ethidium bromide (at the arrow). (C)
Effect of ortho-vanadate on the accumulation of ethidium
bromide in HorA-expressing cells. Cells were treated as described for
panel B.
|
|
(ii) Hoechst 33342 transport in membrane vesicles.
In previous
studies, the positively charged bisbenzimide dye Hoechst 33342 proved
to be a useful probe to study the activity of multidrug transporters
such as LmrA and the human multidrug resistance P-glycoprotein
(5, 8, 20). Hoechst 33342 is highly fluorescent when
it is present in the hydrophobic environment of the phospholipid
bilayer. The transport of Hoechst 33342 from the membrane into the
aqueous phase can be followed as a decrease of Hoechst 33342 fluorescence over time. The ionophores valinomycin and nigericin were
included in this fluorescence assay at a concentration of 0.4 µM to
dissipate the membrane potential and transmembrane pH gradient,
respectively, generated through proton pumping by the
F1F0 H+-ATPase. In the presence of
ATP, Hoechst 33342 fluorescence decreased in HorA-containing membrane
vesicles five-fold faster than in membrane vesicles from control cells.
In the presence of the slowly hydrolyzable ATP analog ATP
S, no
significant decrease of Hoechst 33342 fluorescence was observed in both
types of membrane vesicles (Fig. 4). The ATP-dependent Hoechst 33342 transport in the control cells is most likely due to the presence of
low levels of endogenous LmrA, since under the experimental conditions
employed the secondary multidrug-transporter LmrP cannot work because a
proton motive force is absent. The results demonstrate that in the
presence of Mg-ATP, HorA efficiently transports Hoechst 33342 from the membrane into the lumen of inside-out membrane vesicles prepared from
HorA-expressing L. lactis.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Hoechst 33342 transport in inside-out membrane vesicles
of HorA-expressing cells and nonexpressing cells of L. lactis. Membrane vesicles prepared from HorA-expressing cells (H)
and control cells (C) were diluted to a concentration of 0.5 mg of
membrane protein/ml in buffer containing the ATP regenerating system
(see Materials and Methods) and 0.4 µM of each of the ionophores
valinomycin and nigericin to dissipate the membrane potential and
transmembrane pH gradient, respectively. After incubation for 1 min at
20°C, 2.3 µM Hoechst 33342 was added to the assay mixture. At the
arrow, 2 mM Mg-ATP or 2 mM Mg-ATP S was added. Hoechst
33342 transport was measured at 20°C by fluorimetry.
|
|
(iii) Hoechst 33342 transport in proteoliposomes.
HorA-mediated transport of Hoechst 33342 was also studied using
purified and functionally reconstituted protein. The protein was
solubilized using 0.05% dodecyl maltoside and purified by nickel
chelate affinity chromatography to a high degree of purity (Fig. 1).
HorA was reconstituted by mixing the purified protein with preformed
dodecyl maltoside-destabilized liposomes, composed of L. lactis lipids, after which the detergent was removed by extraction
with polystyrene beads. Transport studies revealed that purified
HorA was able to transport Hoechst 33342 into proteoliposomes in the
presence of ATP (Fig. 5).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Transport of Hoechst 33342 in proteoliposomes. Liposomes
without reconstituted HorA protein (A) and proteoliposomes containing
reconstituted HorA protein (B) were diluted in buffer containing the
ATP regenerating system. After incubation for 1 min at 20°C, 2.3 µM
Hoechst 33342 was added to the assay mixture. At the arrow, 2 mM Mg-ATP
or 2 mM Mg-ATP S was added.
|
|
(iv) Transport of hop compounds by HorA.
If, as indicated by
the above data, HorA functions as a drug transporter with broad drug
specificity, then HorA may also be able to extrude hop compounds. The
specificity of HorA for hop compounds was analyzed in Hoechst 33342 transport assays in which hop compounds were included as competing
substrates (Fig. 6). Because hop
compounds are protonophores that act upon the proton motive force, hop
compounds may also indirectly affect Hoechst 33342 partitioning in the
membrane. Therefore, the ionophores valinomycin and nigericin were
included in the Hoechst 33342 transport assays at final concentrations
of 0.4 µM. The HorA-mediated transport of Hoechst 33342 in the
presence of ionophores was inhibited by hop compounds (Fig. 6). The
degree of inhibition was proportional to the concentration of hop
compounds used, indicating that hop compounds are transport substrates
for HorA.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
HorA displays specificity for hop compounds. The
ATP-dependent transport of Hoechst 33342 in HorA-containing inside-out
membrane vesicles was measured as described in the legend to Fig. 4.
Hop compounds at indicated concentrations were added to the assay
mixture prior to the addition of Hoechst 33342. The hop compounds did
not affect the fluorescence of Hoechst 33342 in control membrane
vesicles without HorA (data not shown). To dissipate a proton motive
force generated by F1F0-ATPase, the ionophores
valinomycin (0.4 µM) and nigericin (0.4 µM) were included in the
assay medium.
|
|
 |
DISCUSSION |
Although hop resistance in L. brevis is known to be
linked to the increased copy number of the horA-containing
plasmid pRH45 (10, 11), the mechanism of hop resistance in
this organism has not been studied previously. To analyze the function
of HorA in greater detail, hexa-histidine-tagged HorA was expressed in L. lactis. By employing the NICE system (3),
high expression levels were obtained of up to 30% of total membrane
protein. Cell fractionation studies indicated that the overexpressed
HorA protein was associated with the plasma membrane in L. lactis. HorA is a member of the ABC superfamily and is a
structural homologue of the multidrug transporter LmrA in L. lactis (21). Therefore, the ability of HorA to act as
a drug pump was investigated. Transport experiments with
HorA-expressing L. lactis cells, HorA-containing inside-out
membrane vesicles, and proteoliposomes containing purified and
functionally reconstituted HorA demonstrated that HorA mediated the
transport of typical LmrA substrates, such as ethidium bromide and
Hoechst 33342. Hence, HorA and LmrA may be functionally equivalent proteins.
Two approaches were used to assess the ability of heterologously
expressed HorA to act as an extrusion system for hop compounds: (i) in
vivo resistance to growth inhibition by hop compounds and (ii) the
competitive inhibition of drug transport by hop compounds. The
increased hop resistance in HorA-expressing L. lactis cells and the inhibition of Hoechst 33342 transport by hop compounds both
indicate that hop compounds are transport substrates of HorA. Hop
compounds are able to dissipate the proton motive force in gram-positive bacteria through a cycling mechanism in which the undissociated iso-
-acids enter the cell by diffusion through the
phospholipid bilayer and, after the dissociation of a proton, diffuse
back to the extracellular environment as anionic species (13, 14,
16, 17). The HorA-mediated resistance of cells to hop compounds
suggests that HorA mediates the extrusion of undissociated
iso-
-acids, by analogy with LmrA and the human multidrug resistance
P-glycoprotein, possibly from the phospholipid bilayer.
Most known bacterial multidrug transporters use the proton motive force
to drive the extrusion of drugs (7). LmrA and HorA represent prokaryotic ABC multidrug transporters that share significant sequence similarity with ABC proteins in Bacillus subtilis,
Staphylococcus aureus, Escherichia coli,
Helicobacter pylori, Haemophilus influenzae, and
Mycoplasma genitalium (21). Studies on the
origin of multidrug resistance genes demonstrate the importance of
transfer of genetic information between microorganisms in the emergence
and spread of multidrug resistance (2). Although the
lmrA gene is carried by the genome of L. lactis,
horA is carried by a plasmid. Hence, prokaryotic members of
the ABC transporter family can potentially be exchanged between
pathogenic microorganisms and may be responsible for acquired multidrug
resistance in these organisms (9).
 |
ACKNOWLEDGMENTS |
We thank M. Sami and H. Nakagawa for valuable discussions and G. Poelarends for drawing some of the figures.
K.S. received a grant from Asahi Breweries, Ltd., A.M. received a TMR
fellowship from the European Community, and H.W.V.V. was a Fellow of
the Royal Netherlands Academy of Sciences (KNAW).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Groningen Biomolecular Sciences and Biotechnology
Institute, University of Groningen, Kerklaan 30, 9751 NN Haren, The
Netherlands. Phone: 31-50-363-21-50. Fax: 31-50-3632154. E-mail:
w.n.konings{at}biol.rug.nel.
Present address: Instituto de Productos Lacteos de Asturias,
IPLA-CSIC, Ctra/Infiesto s/n, 33300 Villaviciosa, Asturias, Spain.
Present address: Department of Pharmacology, University of
Cambridge, CB2 1QJ Cambridge, United Kingdom.
 |
REFERENCES |
| 1.
|
Bolhuis, H.,
H. W. van Veen,
D. Molenaar,
B. Poolman,
A. J. M. Driessen, and W. N. Konings.
1996.
Multidrug resistance in Lactococcus lactis: evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane.
EMBO J.
15:4239-4245[Medline].
|
| 2.
|
Davies, J.
1994.
Inactivation of antibiotics and the dissemination of resistance genes.
Science
264:375-382[Abstract/Free Full Text].
|
| 3.
|
de Ruyter, P. G. G. A.,
O. P. Kuipers, and W. M. de Vos.
1996.
Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin.
Appl. Environ. Microbiol.
62:3662-3667[Abstract].
|
| 4.
|
Higgins, C. F.
1992.
ABC transporters: from microorganisms to man.
Annu. Rev. Cell Biol.
8:67-113[CrossRef].
|
| 5.
|
Margolles, M.,
M. Putman,
H. W. van Veen, and W. N. Konings.
1999.
The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids.
Biochemistry
38:16298-16306[CrossRef][Medline].
|
| 6.
|
Poolman, B.,
A. J. M. Driessen, and W. N. Konings.
1987.
Regulation of arginine-ornithine exchange and the arginine deiminase pathway in Streptococcus lactis.
J. Bacteriol.
169:2755-2761[Abstract/Free Full Text].
|
| 7.
|
Putman, M.,
H. W. van Veen, and W. N. Konings.
2000.
Molecular properties of bacterial multidrug transporters.
Microbiol. Mol. Biol. Rev.
64:672-693[Abstract/Free Full Text].
|
| 8.
|
Putman, M.,
H. W. van Veen,
B. Poolman, and W. N. Konings.
1999.
Restrictive use of detergents in the functional reconstitution of the secondary multidrug transporter LmrP.
Biochemistry
38:1002-1008[CrossRef][Medline].
|
| 9.
|
Putman, M.,
H. W. van Veen,
J. E. Degener, and W. N. Konings.
2000.
Antibiotic resistance: era of the multidrug pump.
Mol. Microbiol.
36:772-774[CrossRef][Medline].
|
| 10.
|
Sami, M.,
K. Suzuki,
K. Sakamoto,
H. Kadokura,
K. Kitamoto, and K. Yoda.
1998.
A plasmid pRH45 of Lactobacillus brevis confers hop resistance.
J. Gen. Appl. Microbiol.
44:361-363.
|
| 11.
|
Sami, M.,
H. Yamashita,
T. Hirono,
H. Kadokura,
K. Kitamoto,
K. Yoda, and M. Yamasaki.
1997.
Hop-resistant Lactobacillus brevis contains a novel plasmid harboring a multidrug resistance-like gene.
J. Ferment. Bioeng.
84:1-6.
|
| 12.
|
Shapiro, A. B., and V. Ling.
1999.
Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.
Eur. J. Biochem.
250:122-129[Medline].
|
| 13.
|
Simpson, W. J.
1993.
Ionophoric action of trans-isohumulone on Lactobacillus brevis.
J. Gen. Microbiol.
139:1041-1045.
|
| 14.
|
Simpson, W. J.
1993.
Studies on the sensitivity of lactic acid bacteria to hop bitter acids.
J. Inst. Brew.
99:405-411.
|
| 15.
|
Simpson, W. J., and J. L. Fernandez.
1992.
Selection of beer spoilage lactic acid bacteria and induction of their ability to grow in beer.
Lett. Appl. Microbiol.
14:13-16.
|
| 16.
|
Simpson, W. J., and J. L. Fernandez.
1992.
Factors affecting antibacterial activity of hop compounds and their derivatives.
J. Appl. Bacteriol.
72:327-334[Medline].
|
| 17.
|
Simpson, W. J., and J. L. Fernandez.
1994.
Mechanism of resistance of lactic acid bacteria to trans-isohumulone.
J. Am. Soc. Brew. Chem.
52:9-11.
|
| 18.
|
van Veen, H. W.,
K. Venema,
H. Bolhuis,
I. Oussenko,
J. Kok,
B. Poolman,
A. J. M. Driessen, and W. N. Konings.
1996.
Multidrug resistance mediated by a bacterial homologue of the human multidrug transporter MDR1.
Proc. Natl. Acad. Sci. USA
93:10668-10672[Abstract/Free Full Text].
|
| 19.
|
van Veen, H. W.,
R. Callaghan,
L. Soceneantu,
A. Sardini,
W. N. Konings, and C. F. Higgins.
1998.
A bacterial antibiotic-resistant gene that complements the human multidrug-resistance P-glycoprotein gene.
Nature (London)
391:291-295[CrossRef][Medline].
|
| 20.
|
van Veen, H. W.,
A. Margolles,
M. Müller,
C. F. Higgins, and W. N. Konings.
2000.
The homodimeric ATP-binding cassette transporter LmrA mediated multidrug transport by an alternating two-site (two cylinder engine) mechanism.
EMBO J.
19:2503-2514[CrossRef][Medline].
|
| 21.
|
van Veen, H. W., and W. N. Konings.
1998.
The ABC family of multidrug transporters in microorganisms.
Biochim. Biophys. Acta
1365:31-36[Medline].
|
Journal of Bacteriology, September 2001, p. 5371-5375, Vol. 183, No. 18
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.18.5371-5375.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Davidson, A. L., Dassa, E., Orelle, C., Chen, J.
(2008). Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems. Microbiol. Mol. Biol. Rev.
72: 317-364
[Abstract]
[Full Text]
-
Matsuo, T., Chen, J., Minato, Y., Ogawa, W., Mizushima, T., Kuroda, T., Tsuchiya, T.
(2008). SmdAB, a Heterodimeric ABC-Type Multidrug Efflux Pump, in Serratia marcescens. J. Bacteriol.
190: 648-654
[Abstract]
[Full Text]
-
Lubelski, J., Konings, W. N., Driessen, A. J. M.
(2007). Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria. Microbiol. Mol. Biol. Rev.
71: 463-476
[Abstract]
[Full Text]
-
Behr, J., Israel, L., Ganzle, M. G., Vogel, R. F.
(2007). Proteomic Approach for Characterization of Hop-Inducible Proteins in Lactobacillus brevis. Appl. Environ. Microbiol.
73: 3300-3306
[Abstract]
[Full Text]
-
Brissette, C. A., Lukehart, S. A.
(2007). Mechanisms of Decreased Susceptibility to {beta}-Defensins by Treponema denticola. Infect. Immun.
75: 2307-2315
[Abstract]
[Full Text]
-
Margolles, A., Florez, A. B., Moreno, J. A., van Sinderen, D., de los Reyes-Gavilan, C. G.
(2006). Two membrane proteins from Bifidobacterium breve UCC2003 constitute an ABC-type multidrug transporter. Microbiology
152: 3497-3505
[Abstract]
[Full Text]
-
Behr, J., Ganzle, M. G., Vogel, R. F.
(2006). Characterization of a Highly Hop-Resistant Lactobacillus brevis Strain Lacking Hop Transport.. Appl. Environ. Microbiol.
72: 6483-6492
[Abstract]
[Full Text]
-
Gottschalk, B., Broker, G., Kuhn, M., Aymanns, S., Gleich-Theurer, U., Spellerberg, B.
(2006). Transport of Multidrug Resistance Substrates by the Streptococcus agalactiae Hemolysin Transporter.. J. Bacteriol.
188: 5984-5992
[Abstract]
[Full Text]
-
Suzuki, K., Iijima, K., Ozaki, K., Yamashita, H.
(2005). Isolation of a Hop-Sensitive Variant of Lactobacillus lindneri and Identification of Genetic Markers for Beer Spoilage Ability of Lactic Acid Bacteria. Appl. Environ. Microbiol.
71: 5089-5097
[Abstract]
[Full Text]
-
Raherison, S., Gonzalez, P., Renaudin, H., Charron, A., Bebear, C., Bebear, C. M.
(2005). Increased Expression of Two Multidrug Transporter-Like Genes Is Associated with Ethidium Bromide and Ciprofloxacin Resistance in Mycoplasma hominis. Antimicrob. Agents Chemother.
49: 421-424
[Abstract]
[Full Text]
-
Lubelski, J., Mazurkiewicz, P., van Merkerk, R., Konings, W. N., Driessen, A. J. M.
(2004). ydaG and ydbA of Lactococcus lactis Encode a Heterodimeric ATP-binding Cassette-type Multidrug Transporter. J. Biol. Chem.
279: 34449-34455
[Abstract]
[Full Text]
-
Mazurkiewicz, P., Poelarends, G. J., Driessen, A. J. M., Konings, W. N.
(2004). Facilitated Drug Influx by an Energy-uncoupled Secondary Multidrug Transporter. J. Biol. Chem.
279: 103-108
[Abstract]
[Full Text]
-
Lee, E.-W., Huda, M. N., Kuroda, T., Mizushima, T., Tsuchiya, T.
(2003). EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis. Antimicrob. Agents Chemother.
47: 3733-3738
[Abstract]
[Full Text]
-
Gajic, O., Buist, G., Kojic, M., Topisirovic, L., Kuipers, O. P., Kok, J.
(2003). Novel Mechanism of Bacteriocin Secretion and Immunity Carried Out by Lactococcal Multidrug Resistance Proteins. J. Biol. Chem.
278: 34291-34298
[Abstract]
[Full Text]
-
Seigneuret, M., Garnier-Suillerot, A.
(2003). A Structural Model for the Open Conformation of the mdr1 P-glycoprotein Based on the MsbA Crystal Structure. J. Biol. Chem.
278: 30115-30124
[Abstract]
[Full Text]
-
Huda, N., Lee, E.-W., Chen, J., Morita, Y., Kuroda, T., Mizushima, T., Tsuchiya, T.
(2003). Molecular Cloning and Characterization of an ABC Multidrug Efflux Pump, VcaM, in Non-O1 Vibrio cholerae. Antimicrob. Agents Chemother.
47: 2413-2417
[Abstract]
[Full Text]
-
Hamasaki, Y., Ayaki, M., Fuchu, H., Sugiyama, M., Morita, H.
(2003). Behavior of Psychrotrophic Lactic Acid Bacteria Isolated from Spoiling Cooked Meat Products. Appl. Environ. Microbiol.
69: 3668-3671
[Abstract]
[Full Text]
-
Sakamoto, K., van Veen, H. W., Saito, H., Kobayashi, H., Konings, W. N.
(2002). Membrane-Bound ATPase Contributes to Hop Resistance of Lactobacillus brevis. Appl. Environ. Microbiol.
68: 5374-5378
[Abstract]
[Full Text]
-
Ulmer, H. M., Herberhold, H., Fahsel, S., Ganzle, M. G., Winter, R., Vogel, R. F.
(2002). Effects of Pressure-Induced Membrane Phase Transitions on Inactivation of HorA, an ATP-Dependent Multidrug Resistance Transporter, in Lactobacillus plantarum. Appl. Environ. Microbiol.
68: 1088-1095
[Abstract]
[Full Text]